Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021Azalea Thomson, Deepa Dongarwar, Theresa A. McHugh et al.|The Lancet Haematology|2023Cited by 674
Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021William M. Gardner, Rajaa Al‐Raddadi, Leo Zoeckler et al.|The Lancet Haematology|2023Cited by 541
Tracking US Health Care Spending by Health Condition and CountyJoseph L. Dieleman, Christopher J L Murray, Sawyer W Crosby et al.|JAMA|2025Cited by 40
Global burden of sickle cell disease in 2021 – Authors' replyNicholas J Kassebaum, Christopher J L Murray, Taylor Noyes et al.|The Lancet Haematology|2023Cited by 3
Exploring State‐Level Change in Health Care Value Over Three Decades in the United States, 1991–2020Haley Lescinsky, Arnold Milstein, Maitreyi Sahu et al.|Health Services Research|2025Cited by 0